A diagnostics platform that makes liquid biopsies a reality in cancer care
Hedera Dx has raised $17.1M in total funding. The most recent round was Series A. The last funding was announced in May 2025.
Hedera Dx's investors include Vsquared Ventures, Inventure, Tesi, Air Street Capital, GRIDS Capital.
Hedera Dx is headquartered in Epalinges, Switzerland.
A diagnostics platform that makes liquid biopsies a reality in cancer care
Hedera Dx is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Hedera Dx — Funding & Investors." VCBacked, May 27, 2025, https://www.vcbacked.co/company/hedera-dx. Accessed September 10, 2026.
VCBacked. (2025). Hedera Dx — Funding & Investors. Retrieved September 10, 2026, from https://www.vcbacked.co/company/hedera-dx
{{cite web |title=Hedera Dx — Funding & Investors |url=https://www.vcbacked.co/company/hedera-dx |website=VCBacked |access-date=September 10, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated